Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Specializing In
- Adrenal Tumors
- Bladder Cancer
- Chronic Myeloid Leukemia (CML)
- Chronic Myelomonocytic Leukemia
- Cutaneous Lymphoma
- Desmoid Tumor
- Mediastinal Masses
- Multiple Myeloma
Biography
Lynn Million specializes in the treatment of cancer. She has practiced Radiation Oncology for more than 30 years. Dr. Million has a special interest in the treatment of sarcoma’s of soft tissue, bone and cartilage in children, young adolescents and adults.
View Full Biography »
Professional Summary
Professional Education
- Fellowship: Stanford University Dept of Radiation Oncology (2020) CA
- Fellowship: Stanford University Dept of Radiation Oncology (1991) CA
- Internship: Wellstar Atlanta Medical Center Internal Medicine Residency (1987) GA
- Medical Education: University of Florida Office of Student Affairs (1986) FL
- Residency: Stanford University Radiation Oncology Residency (1990) CA
- Board Certification: American Board of Radiology, Radiation Oncology (1991)
Publications
-
Undifferentiated High-Grade Pleomorphic Sarcomas in Children: A Clinicopathologic Study of 10 Cases and Review of Literature
Alaggio, R., Collini, P., Randall, R. L., Barnette, P., Million, L., & Coffin, C. M. (2010). Undifferentiated High-Grade Pleomorphic Sarcomas in Children: A Clinicopathologic Study of 10 Cases and Review of Literature. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 13(3), 209–217. -
INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Million, L., Anderson, J., Breneman, J., Hawkins, D. S., Laurie, F., Michalski, J., … Donaldson, S. S. (2011). INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 80(2), 333–38. -
Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803-A Report From the Children's Oncology Group
Minn, A. Y., Lyden, E. R., Anderson, J. R., Million, L., Arndt, C. A., Brown, K., … Donaldson, S. S. (2010). Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803-A Report From the Children's Oncology Group. JOURNAL OF CLINICAL ONCOLOGY, 28(27), 4228–32. -
Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the children's oncology group.
Rodeberg, D. A., Stoner, J. A., Garcia-Henriquez, N., Randall, R. L., Spunt, S. L., Arndt, C. A., … Hawkins, D. S. (2010). Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the children's oncology group. Cancer. -
Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much?
Million, L., & Donaldson, S. S. (2012). Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much? ISRN Oncology, 2012, 341408-? -
Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome
Henry, E., Villalobos, V., Million, L., Jensen, K. C., West, R., Ganjoo, K., … Telli, M. L. (2012). Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(8), 939–42. -
Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?
Gamba, C. A., Wysong, A., Million, L., Aasi, S., Kim, J., & Tang, J. Y. (2012). Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma? JOURNAL OF CLINICAL ONCOLOGY, 30(32), E333–E336. -
Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: A report from the Children's Oncology Group
Raney, B., Huh, W., Hawkins, D., Hayes-Jordan, A., Million, L., Rodeberg, D., … Anderson, J. (2013). Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: A report from the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 60(3), 371–376. -
Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
Hiniker, S. M., Agarwal, R., Modlin, L. A., Gray, C. C., Harris, J. P., Million, L., … Donaldson, S. S. (2014). Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement. International Journal of Radiation Oncology, Biology, Physics, 89(1), 67–74. -
Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials.
Hoppe, R. T., Harrison, C., Tavallaee, M., Bashey, S., Sundram, U., Li, S., … Kim, Y. H. (2015). Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials. Journal of the American Academy of Dermatology, 72(2), 286–92. -
Successful Treatment with Temozolomide Combined with Chemoradiotherapy and Surgery of a Metastatic Undifferentiated Soft Tissue Sarcoma with Relapse in the Central Nervous System of a Young Adult
Hsu, C. H., Daldrup-Link, H. E., Yeom, K. W., Donaldson, S. S., Million, L., Hazard, F. K., & Rangaswami, A. (2014). Successful Treatment with Temozolomide Combined with Chemoradiotherapy and Surgery of a Metastatic Undifferentiated Soft Tissue Sarcoma with Relapse in the Central Nervous System of a Young Adult. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 3(2), 100–103. -
Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Gratzinger, D., Million, L., & Kim, Y. H. (2015). Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma. American Journal of Dermatopathology, 37(10), 767–70. -
The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation
King, M. T., Modlin, L., Million, L., Donaldson, S. S., Gibbs, I. C., Choi, C. Y. H., & Soltys, S. G. (2016). The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 15(3), 472–79. -
Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience.
Million, L., Yi, E. J., Wu, F., von Eyben, R., Campbell, B. A., Dabaja, B., … Hoppe, R. T. (2016). Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience. International Journal of Radiation Oncology, Biology, Physics, 95(5), 1454–59. -
NCCN Guidelines (R) Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines
Biermann, J. S., Chow, W., Reed, D. R., Lucas, D., Adkins, D. R., Agulnik, M., … Scavone, J. L. (2017). NCCN Guidelines (R) Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 15(2), 155–67. -
A Robust and Affordable Table Indexing Approach for Multi-isocenter Dosimetrically Matched Fields.
Yu, A., Fahimian, B., Million, L., & Hsu, A. (2017). A Robust and Affordable Table Indexing Approach for Multi-isocenter Dosimetrically Matched Fields. Cureus, 9(5), e1270. -
Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors.
Moding, E. J., Million, L., Avedian, R., Ghanouni, P., Kunder, C., & Ganjoo, K. N. (2017). Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors. Sarcoma, 2017, 2316839. -
The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma
Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma. The Journal of Thoracic and Cardiovascular Surgery. -
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Hawkins, D. S., Chi, Y.-Y., Anderson, J. R., Tian, J., Arndt, C. A., Bomgaars, L., … Meyer, W. H. (2018). Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2018779694. -
Evaluating Barriers and Opportunities in Delivering High-Quality Oncology Care in a Resource-Limited Setting Using a Comprehensive Needs Assessment Tool.
Nwachukwu, C. R., Mudasiru, O., Million, L., Sheth, S., Qamoos, H., Onah, J. O., … Bhatt, A. S. (2018). Evaluating Barriers and Opportunities in Delivering High-Quality Oncology Care in a Resource-Limited Setting Using a Comprehensive Needs Assessment Tool. Journal of Global Oncology, (4), 1–9. -
The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
Kamat, N. V., Million, L., Yao, D.-H., Donaldson, S. S., Mohler, D. G., van de Rijn, M., … Ganjoo, K. N. (2018). The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University. American Journal of Clinical Oncology. -
Larry Emanuel Kun, March 10, 1946-May 27, 2018.
FitzGerald, T. J., Donaldson, S. S., Wharam, M., Laurie, F., Bishop-Jodoin, M., Moni, J., … Roberts, K. B. (2019). Larry Emanuel Kun, March 10, 1946-May 27, 2018. International Journal of Radiation Oncology, Biology, Physics, 103(1), 8–14. -
Preoperative Intensity Modulated Radiation Therapy Compared to Three-Dimensional Conformal Radiation Therapy for High-Grade Extremity Sarcomas in Children: Analysis of the Children's Oncology Group Study ARST0332.
Rao, A. D., Chen, Q., Million, L., Spunt, S. L., Fitzgerald, T. J., Hu, C., … Terezakis, S. A. (2019). Preoperative Intensity Modulated Radiation Therapy Compared to Three-Dimensional Conformal Radiation Therapy for High-Grade Extremity Sarcomas in Children: Analysis of the Children's Oncology Group Study ARST0332. International Journal of Radiation Oncology, Biology, Physics, 103(1), 38–44. -
Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018.
Jabbour, S. K., Timmerman, R. D., Raben, D., DeWeese, T. L., Donaldson, S. S., Thomas, P., … FitzGerald, T. J. (2019). Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. International Journal of Radiation Oncology, Biology, Physics, 103(5), 1026–30. -
Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features.
Siwillis, E. M., Dharse, N. J., Scanlan, T., Ngoma, M., Abraham, Z. S., Kahiu, J. W., & Million, L. (2019). Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features. Journal of Global Oncology, (5), 1–6. -
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
Spunt, S. L., Francotte, N., De Salvo, G. L., Chi, Y.-Y., Zanetti, I., Hayes-Jordan, A., … Ferrari, A. (2019). Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials. European Journal of Cancer (Oxford, England : 1990), 112, 98–106. -
The impact of postoperative therapy on primary cardiac sarcoma.
Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The impact of postoperative therapy on primary cardiac sarcoma. The Journal of Thoracic and Cardiovascular Surgery, 156(6), 2194–2203. -
The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University
Kamat, N. V., Million, L., Yao, D.-han, Donaldson, S. S., Mohler, D. G., van de Rijn, M., … Ganjoo, K. N. (2019). The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 42(2), 166–71. -
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials
Spunt, S. L., Francotte, N., De Salvo, G. L., Chi, Y.-Y., Zanetti, I., Hayes-Jordan, A., … Ferrari, A. (2019). Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials. EUROPEAN JOURNAL OF CANCER, 112, 98–106. -
Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features
Siwillis, E. M., Dharse, N. J., Scanlan, T., Ngoma, M., Abraham, Z. S., Kahiu, J. W. N., & Million, L. (2019). Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features. JOURNAL OF GLOBAL ONCOLOGY, 5. -
Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy.
Chen, E. L., Yoo, C. H., Gutkin, P. M., Merriott, D. J., Avedian, R. S., Steffner, R. J., … Hiniker, S. M. (2019). Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy. Pediatric Blood & Cancer, e27967. -
Preoperative chemoradiation plus /- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.
Weiss, A. R., Chi, Y.-Y., Chen, Y.-L., Choy, E., Davis, J. L., Fanburg-Smith, J., … Black, J. O. (2019). Preoperative chemoradiation plus /- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology. JOURNAL OF CLINICAL ONCOLOGY, 37(15). -
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Spunt, S. L., Million, L., Chi, Y.-Y., Anderson, J., Tian, J., Hibbitts, E., … Hawkins, D. S. (2019). A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study. The Lancet. Oncology. -
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.
Berlow, N. E., Grasso, C. S., Quist, M. J., Cheng, M., Gandour-Edwards, R., Hernandez, B. S., … Keller, C. (2020). Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma. Sarcoma, 2020, 6312480. -
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Weiss, A. R., Chen, Y.-L. L., Scharschmidt, T. J., Chi, Y.-Y. Y., Tian, J., Black, J. O., … Wang, D. (2020). Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial. The Lancet. Oncology. -
Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Morris, C. D., Tunn, P.-U., Rodeberg, D. A., Terwisscha van Scheltinga, S., Binitie, O., Godzinski, J., … Rogers, T. N. (2020). Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatric Blood & Cancer, e28608. -
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.
Weng, W.-K. K., Arai, S., Rezvani, A., Johnston, L., Lowsky, R., Miklos, D., … Kim, Y. H. (2020). Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Advances, 4(18), 4474–82. -
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
Gallego, S., Chi, Y.-Y. Y., De Salvo, G. L., Li, M., Merks, J. H., Rodeberg, D. A., … Hawkins, D. S. (2020). Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Pediatric Blood & Cancer, e28832. -
Non-rhabdomyosarcoma soft-tissue sarcoma.
Milgrom, S. A., Million, L., Mandeville, H., Safwat, A., Ermoian, R. P., & Terezakis, S. (2021). Non-rhabdomyosarcoma soft-tissue sarcoma. Pediatric Blood & Cancer, 68 Suppl 2, e28279. -
CT-less electron radiotherapy simulation and planning with a consumer 3D camera.
Skinner, L., Knopp, R., Wang, Y.-C., Dubrowski, P., Bush, K. K., Limmer, A., … Yu, A. S. (2021). CT-less electron radiotherapy simulation and planning with a consumer 3D camera. Journal of Applied Clinical Medical Physics. -
Uterine Leiomyosarcoma with FN1-Anaplastic Lymphoma Kinase Fusion Responsive to Alectinib and Lorlatinib.
Testa, S., Million, L., Longacre, T., & Bui, N. (2021). Uterine Leiomyosarcoma with FN1-Anaplastic Lymphoma Kinase Fusion Responsive to Alectinib and Lorlatinib. Case Reports in Oncology, 14(2), 812–819. -
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology Group
Million, L. (2021). Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology Group. Int J Radiat Oncol Biol Phys, 110(3). -
Outcomes following preoperative chemoradiation plus /- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.
Weiss, A. R., Chen, Y.-L., Scharschmidt, T., Xue, W., Gao, Z., Black, J. O., … Spunt, S. L. (2022). Outcomes following preoperative chemoradiation plus /- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.
Baniel, C., Yoo, C. H., Jiang, A., von Eyben, R., Mohler, D. G., Ganjoo, K., … Hiniker, S. M. (2022). Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy. Practical Radiation Oncology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery »
- Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides »
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma »
Practice Locations
Radiation Oncology Clinic in San Jose San Jose, CA
San Jose, CA
Radiation Oncology Clinic in San Jose
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Sarcoma Program in South Bay San Jose, CA
San Jose, CA
Sarcoma Program in South Bay
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Cancer Center in South Bay San Jose, CA
San Jose, CA
Cancer Center in South Bay
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Patient Reviews
(100 reviews)
ALL GOOD.
She is a good doctor
She is kind, concerned and highly professional.
I think Dr Million is the absolute best. She’s thorough, understanding, knowledgeable and Very kind person
Dr. Million is a great physician!
Dr.Million is an amazing provider. Understanding medical terminology can be difficult, but her choice of words when talking to a patient are very clear.
Radiation performed seems to have worked well
Strangely, I like her even more in video visits. Maybe we're both more relaxed?
I have full confidence in Dr. Million, which goes a long way in my healing and in my quality of life.
Dr. Million was very informative and supportive. She answered all my questions and did not make me feel rushed. After meeting with her I felt more at ease with where I am health wise. I’m really happy that I will continue to visit with her.
Love Dr Millon
Dr. Million is a great doctor, very patient and answered all my questions. Thank you !
The doctor and her staff were very nice and everyone was on time!
Really like Dr. Million. Easy to talk to and seems like she really cares about her patients. Thank you for all your feedback today Dr. Million.
Dr. Million is thorough, kind, and listens well to my questions.
She is AMAZING!!!
Appointment was very good as usual. I have great confidence in Dr Million
Dr Million is very thorough and attentive. I like her much.
Very well explained
Very thorough.
Dr. Million and Junile were great, thanks
Dr Million has always treated with understanding and compassion.
For over 2 years she has gone over my PetScans and imaging with me answering any and all questions that I have had. She is a good listener and makes sure that she has addressed all of my concerns before ending our appointment.
I’ve never felt rushed. She gives me as much time as I need.
She and her team are the BEST!
I would recommend her to anyone.
Dr explained to me Really well about Everything .
Dr. million is a clear, patient, informative, kind and brilliant physician.. I'm honored to be under her care for adrenal gland radiation.
Very professional, knowledgeable, balanced, and caring. She tried very hard to answer my questions and/or to provide a framework for me to address those questions that only I can really answer.
Dr. Million is very helpful to understand my current health issues.
Friendly, efficient and provides answers and explains in lay terms as needed.
She gave me a thorough, easy to understand explanation of the findings of my pathology report, explained the recommendations for treatment in terms I understood, and gave me a chance to ask questions. I felt that plenty of time was allowed for the session, and didn’t feel like we were hurrying through the visit
Excellent, supportive, informative, easy to understand, always a pleasure to see and work with her.
Dr. Million clearly covered all aspects of the treatment and results thus far. She explained what future results to expect
Really helpful and was able to multitask, setting up treatment, while answering my questions.
I am extremely grateful for the care that I received and am receiving from Dr. Million.
Thank you for the exercise suggestion and will try it daily.
She’s the best.
An excellent coverage of my condition and a pleasant experience.
Dr. Millions went above and beyond for my treatment
Great Doctor and would highly recommend to anyone.
My recent visit was very good. Dr Million makes it so comfortable and I would recommend her without hesitation to anyone who requires her expertise!
Dr.Million is a very thorough and pleasant physician. She took the time to give me good advice and answered all my questions patiently and thoroughly. I would highly recommend,
complete satisfaction
She’s the best.
Dr. Million and her nurse, Junile, are simply the best! I have been with them for five years, and they have seen me through the toughest times. I can’t say enough about the positive and encouraging care the have provided me.
Dr. Million is very thorough and concise in her after visit summaries. I am reminded of things in that report that perhaps I didn't hear or retain from our video visit.
She appears to be a very dedicated and competent radiologist and I'm pleased to have her as one of my doctors--and available in the Cancer Center South Bay so I don't have the long arduous trip to Palo Alto!
The care by almost all caregivers at Stanford are exceptional.
I greatly appreciate Dr. Million's expertise and professionalism.
Dr. Million is personable, kind and through. A very good doctor.
She is a very good doctor...if you are having a problem, she is there with you to solve it....she goes out of her way to make you feel comfortable..and she listens to you...some doctors are thinking about something else when you are talking to them...not Dr Million...
She is a great doctor â ¤
I always recommend your facility
keep up the good work
Thank you for your help and support. and especially finding someone locally that could manage the radiation.
She’s one of the best doctors I ever had
Helpful, efficient, knowledgeable, and caring.
Dr. Million has been so supportive and thorough during my treatment and follow-up. I feel so very fortunate to be in her care.
1. She is great. But I suspect everybody knows that.
Dr. Million covered everything that I needed to proceed forward. Thank you
All good.
Great resource, very knowledgeable.
Very attentive and clarified anything that was not clear to her. Very proactive about helping me with my pain to feel better.
she is very capable .
Very happy with the services I received. She listens to me and answers my questions.
All the above are better than very good... exceptional!
Dr. Million is always the best!
Very informative.
Dr. Million & her staff were terrific. I have great confidence in her.
Dr. Million is the best of the best!
Dr. Million is amazing. She's warm and caring. We never feel rushed. Always feel important.
I have 100% confidence in Dr. Million and her assistants & advice.
Dr. Million was wonderful. She went beyond the normal to care for my skin during radiation because I have lupus. She did an excellent job!
Good experience.
Dr. Million is excellent at explaining cancer treatment and its side effects, and the difference between pet and CT scans and the results of both. She helped me get through the anxiety of my radiation treatment and the continuing side affects of surgery, chemo and radiation.
All good.
Dr. Million is a gem.
Love Dr. Million.
Doctor Million was awesome!
2. Could have gone into a bit more detail. EG instructions were to avoid sunlight. Ok. But family doc emphasized that by talking about a DNA/RNA repair mechanism that shuts down during radiation - Much more persuasive.
Dr. Million is an exceptional doctor.
Dr. Million was better at explaining my diagnosis than any of the other oncologists I've had. Her presence was professional, calm, and comforting.
Not necessarily bad, but not enough or incorrect info given by one dr. about what the other dr. will be doing on a next or new visit. Maybe I need to be more direct in asking exactly what is going to be done etc. on another visit.
Dr. Million & staff are fabulous.
Dr. Million is a wonderful, caring and informative doctor. I could not ask for better care and I feel very fortunate to have her care.
Dr. Million excellent as was her resident fellow.
Dr. Million is an amazing doctor, very caring, knowledgeable professional and patient. Extremely thorough and trustworthy. Her care is excellent and I'm thankful.
Her competence and depth of knowledge are outstanding.
Dr. Million is the best! She is compassionate, knowledgeable and terrific!
Dr. Million and her staff are excellent.
Bravo!
Dr. Million and the entire staff in radiation oncology are amazing.
Good experience.
Dr. Million was excellent.
Dr. Million and staff are the greatest!
Everyone in staff at Stanford very helpful and pleasant.
Dr. Million is awesome - Very caring, knowledgeable & accessible.
Very good.
Dr. Million's complete & clear discussion about my serious medical condition was very appreciated. Her explanations & thought process were clear and easy to understand for myself & my husband.
I recommend your doctors & facility to every one I know.
Dr. Million is a wonderful doctor! I am so lucky and grateful to have her as a provider.
Although I have high confidence in where we are headed, I would like to have been asked if I had any questions and reassured that ultimately I had the choice of what treatment I wanted to undergo.
Good.
Dr. Million is exceptional! Caring, knowledgeable and empathetic - The best.
Dr. Million is excellent! Compassionate, excellent clinician.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- View referral status
- Access medical records